Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Interest & Investment Income: 2012-2024

Historic Interest & Investment Income for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to $27.7 million.

  • Ascendis Pharma A's Interest & Investment Income fell 77.28% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.8 million, marking a year-over-year decrease of 14.61%. This contributed to the annual value of $27.7 million for FY2024, which is 41.26% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Interest & Investment Income of $27.7 million as of FY2024, which was down 41.26% from $47.2 million recorded in FY2023.
  • Ascendis Pharma A's Interest & Investment Income's 5-year high stood at $68.3 million during FY2021, with a 5-year trough of $2.1 million in FY2020.
  • In the last 3 years, Ascendis Pharma A's Interest & Investment Income had a median value of $47.2 million in 2023 and averaged $42.7 million.
  • Per our database at Business Quant, Ascendis Pharma A's Interest & Investment Income soared by 7,270.48% in 2020 and then tumbled by 41.26% in 2024.
  • Yearly analysis of 5 years shows Ascendis Pharma A's Interest & Investment Income stood at $2.1 million in 2020, then surged by 3,202.04% to $68.3 million in 2021, then declined by 22.07% to $53.2 million in 2022, then declined by 11.36% to $47.2 million in 2023, then tumbled by 41.26% to $27.7 million in 2024.